]>
IRCT20120201008897N7 IRCT 2019-05-02 Esfahan University of Medical Sciences Effects of dienogest and oral contraceptive pills on endometriosis symptoms after laparoscopic surgery Comparative study on the effects of continuous administration of dienogest and continuous oral contraceptive pills on the recurrence of endometriosis symptoms after laparoscopic surgery 2019-06-15 anticipated 80 Complete https://irct.ir/trial/38587 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: In this study, randomization is block type, with blocks of size four. Before assigning the patients to two treatment groups, a container containing the letters A and B is provided with the number of participants with equal beads. The letters indicate the type of the intervention. The beads are drawn out randomly, and this work is continued until the beads are finished. Participant's sequencing is made with the created groups on the sequencing site: http://sealedenvelope.com, Blinding description: In this study the outcome assessor and data analyzer don't know which participant has received dinogest and which one has received oral contraceptives. 3 laparoscopy of endometriosis. Intervention 1: Intervention group 1: group receiving dinogest 2mg/day continuously after surgery for 6 months. Intervention 2: Intervention group 2 : group receiving oral contraceptive (low dose monophasic) every day continuously after surgery for 6 months. Yes - There is a plan to make this available What will be shared: comparing the effects of dinogest and oral contraceptives in reducing the recurrence of endometriosis after laparoscopy When: The time of accessibility is a month after publishing the information To whom: The information is available for everyone Conditions: The information is available for everyone and everyone is allowed to do any kind of analyses on them Where to obtain: address: University of medical siences, Hezar jarib strees, Darvazeh Shiraz, Isfahan postal code:1417614411 phone:00983136202020 website://alzahra.mui.ac.ir Dr Safoura Rouholamin How to obtain: The demandant should send her/his name, occupation, field of studying and purpose in an email. The requested information will be sent in a week Comments:
public Reihaneh Valian Broujeni
Shahid BeheshtiShahid Beheshti Hospital, Motahari Street, Felezi Bridge
Isfahan Iran (Islamic Republic of) 8815515637 +98 31 3236 7001 s_rouholamin@med.mui.ac.ir Esfahan University of Medical Sciences scientific Safoura Rouholamin
Street address Shahid Beheshti Hospital, Motahari Street, Felezi Bridge
Isfahan Iran (Islamic Republic of) 8174673461 +98 31 3236 7001 s_rouholamin@med.mui.ac.ir Esfahan University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Patients with diagnosis endometriosis via laparoscopy Premenopausal patients Patients who have symptoms of endometriosis before surgery (eg: dysmenorrhea, dyspareunia, chronic pelvic pain) Patients who have been referred to Isfahan's Alzhra and Shahid Beheshty hospitals Patients who do not have any decision for pregnancy during this study Patients with 20-40 years of age 20 years 40 years Female Any hormonal therapy 3 months before surgery Having contraindications for using oral contraceptives Changing in the address so there is no access to the patient and her information History of surgery for treatment of endometriosis History of sexual dysfunction in patient or the partner Clients who undergo hysterectomy or ouophurectomy during surgery History of malignancy or heart disease N80.9 Endometriosis, unspecified Prevention Prevention Intervention group 1: group receiving dinogest 2mg/day continuously after surgery for 6 months Intervention group 2 : group receiving oral contraceptive (low dose monophasic) every day continuously after surgery for 6 months Recurrence of endometriosis. Timepoint: 6 months. Method of measurement: visual analog scale, WHO quality of life brief (WHOQOL-BREF) , Female Sexual Function Index (FSFI). Pain. Timepoint: 6 months. Method of measurement: visual analog scale, WHO quality of life brief ( WHOQOL-BREF), Female sexual function index (FSFI). Esfahan University of Medical Sciences Approved 2019-03-12 Isfahan University of Medical Sciences Isfahan University of Medical Sciences, Hezarjerib Street Isfahan Isfehan Iran (Islamic Republic of)